CA-ASM-GLOBAL
9.8.2024 15:01:31 CEST | Business Wire | Press release
ASM Global’s culinary division SAVOR, which provides elevated food experiences for the globe’s most prestigious arenas, stadiums, convention/exhibition centers and performing arts venues, has announced the national winners of the American round of the world’s only competition for young culinary and hospitality talent.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240809474691/en/
Mixologist Winner Marco Guillen, Four Seasons, Napa Valley, California. (Photo: Business Wire)
Thomas Mendel, chef from Hamel Winery; Jaclyn Bisantz, waitress from Harbor House; and Marco Guillen, mixologist from Four Seasons Napa, were crowned as winners of the U.S. leg of the renowned World Young Chef Young Waiter Young Mixologist (WorldYYY) competition — the only event of its kind.
“This syncs very nicely with the work ASM Global does nationally to develop deep relationships with our local communities and reach out to educate, train and employ culinary talent via scholarship, internship and apprenticeship programs,” said Shaun Beard, SAVOR’s senior vice present of food and beverage.
“As ASM Global continues to elevate the food experience in many of the world’s premiere venues, these up-and-coming talents will be part of our universe,” Beard said. “The composure, creativity and determination we’ve seen from all the competitors in this high-pressure situation was truly unmatched and is proof that we have so much to look forward to from these young stars. We are proud to help pave the way for them and are excited to see what they do next.”
SAVOR’s Team USA members will next compete in the WorldYYY finals at Swissôtel The Stamford in Singapore this November. They will showcase their abilities to world-class chefs, hospitality experts and esteemed mixologists. A total of 36 contestants from 12 countries will compete for the world titles of Best Young Chef, Young Waiter and Young Mixologist.
The finals of YYY USA recently took place at the prestigious The Culinary Institute of America at Copia (CIA) in Napa, California, with a panel of expert judges, including Master Chef Roland Passot, propriétaire and chief culinary officer; Tournament of Champions’ Tracey Shepos Cenami, executive chef and cheese specialist at Kendall-Jackson Wine Estate and Gardens; and Food Network Chef Adam Sobel, partner of Mina Group anointing the winners.
ASM Global’s SAVOR division became a strategic partner of the competition nearly five years ago as part of its worldwide commitment to nurturing and identifying new talent, introducing them to the hospitality space and showcasing them to renowned culinary industry leaders.
About SAVOR
SAVOR is the culinary division of ASM Global, the world’s No. 1 development and full-service venue company with a portfolio of more than 400 of the world’s most prestigious arenas, stadiums, convention/exhibition centers and performing arts venues network spanning five continents. The team at SAVOR provides elevated and curated guest experiences at every event, from the food preparation to the beverage offerings, whether for intimate VIP experiences or banquets with over 20,000 guests. In addition to authentic, chef-driven food, the core elements of SAVOR's food vision include partnerships with local growers, producers and community members; a commitment to using antibiotic-free meats and poultry; and dedication to minimizing impact on the environment through robust sustainability, recycling and composting programs. For more information, please visit savorasmglobal.com.
About YYY
Since its establishment in 1979, the Young Chef Young Waiter competition has continued to promote hospitality as a career of choice, a profession and a vocation. Today, with its new revitalized format, Young Chef Young Waiter continues to honor the next culinary and service stars globally. World Young Chef Young Waiter Young Mixologist’s, in partnership with Great Campaign U.K. and Northern Ireland and The Culinary Institute of America, mission is to discover the best young talents in the industry. The competition is open to young chefs, waiters and mixologists age 28 and under from diverse backgrounds. YYY ensures these young talents are equipped with relevant skills, current knowledge and a network to help them succeed in the world of hospitality.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240809474691/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom